Viveve Medical Inc
OTC:VIVE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Viveve Medical Inc
OTC:VIVE
|
US |
|
P
|
Pyramid Technoplast Ltd
NSE:PYRAMID
|
IN |
|
G
|
Guangdong Huafeng New Energy Technology Co Ltd
SZSE:002806
|
CN |
|
Bajaj Finance Ltd
NSE:BAJFINANCE
|
IN |
|
Tata Motors Passenger Vehicles Ltd
NSE:TMPV
|
IN |
|
Telefonica Brasil SA
BOVESPA:VIVT3
|
BR |
|
H
|
Hengdeli Holdings Ltd
HKEX:3389
|
HK |
|
Oenon Holdings Inc
TSE:2533
|
JP |
|
Totvs SA
BOVESPA:TOTS3
|
BR |
|
O
|
Oriental Times Media Corp
SZSE:002175
|
CN |
|
KMD Brands Ltd
NZX:KMD
|
NZ |
Viveve Medical Inc
Viveve Medical, Inc. engages in the design, development, manufacture, and marketing of platform medical technology. The company is headquartered in Englewood, Colorado and currently employs 47 full-time employees. The firm's CMRF technology is delivered through a radiofrequency (RF) generator, handpiece and treatment tip, that collectively, is referred to as the Viveve System. The Viveve System is marketed for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence (SUI), which is known as Viveve treatment. The Viveve System uses a method of delivering monopolar radiofrequency (RF) energy for treating tissue, such as Monopolar Radiofrequency Energy. The Viveve System also uses a cryogen surface cooling that enables volumetric heating of vaginal tissue. The Viveve System also uses a proprietary, controlled cryogen surface cooling that enables deep volumetric heating of vaginal tissue. The firm's subsidiary includes Viveve, Inc. and Viveve BV.
Viveve Medical, Inc. engages in the design, development, manufacture, and marketing of platform medical technology. The company is headquartered in Englewood, Colorado and currently employs 47 full-time employees. The firm's CMRF technology is delivered through a radiofrequency (RF) generator, handpiece and treatment tip, that collectively, is referred to as the Viveve System. The Viveve System is marketed for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence (SUI), which is known as Viveve treatment. The Viveve System uses a method of delivering monopolar radiofrequency (RF) energy for treating tissue, such as Monopolar Radiofrequency Energy. The Viveve System also uses a cryogen surface cooling that enables volumetric heating of vaginal tissue. The Viveve System also uses a proprietary, controlled cryogen surface cooling that enables deep volumetric heating of vaginal tissue. The firm's subsidiary includes Viveve, Inc. and Viveve BV.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
